Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections
Go back to Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections| ANV Security Group, Inc. (NYSE: ANVS) | Delayed: 1.74 -0.03 (1.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.77 | 52 Week High | $0.04 | |||
| Open | $1.72 | 52 Week Low | $0.01 | |||
| Day High | $1.80 | P/E | N/A | |||
| Day Low | $1.71 | EPS | $-0.03 | |||
| Volume | 670,747 | |||||
| ANV Security Group, Inc. (NYSE: ANVS) | Delayed: 1.74 -0.03 (1.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.77 | 52 Week High | $0.04 | |||
| Open | $1.72 | 52 Week Low | $0.01 | |||
| Day High | $1.80 | P/E | N/A | |||
| Day Low | $1.71 | EPS | $-0.03 | |||
| Volume | 670,747 | |||||
